INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture
Conclusion: Intravitreal melphalan and/or topotecan injection for retinoblastoma vitreous seeding provides lasting tumor control at 3 years with approximately 4 injections.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research
More News: Allergy | Allergy & Immunology | Cataract Removal | Cataracts | Chemotherapy | Cryotherapy | Eye Cancers | Eyes | Glaucoma | Opthalmology | Retinoblastoma | Study